Targeted Nudges Boost Serious Illness Conversations in Cancer Care
Event summary
- A study published in the June 2026 issue of JNCCN found that combining clinician reminder emails and patient letters increased serious illness conversations by 79% among cancer patients with poor prognoses.
- The randomized controlled trial involved 1,051 patients and 160 clinicians across two academic cancer centers from December 2022 to September 2024.
- The nudges were limited to patients starting treatments associated with poor prognoses and capped at three visits to avoid alert fatigue.
- The clinician nudge was the primary driver of the benefit, suggesting small, well-timed supports can help clinicians prioritize these conversations.
The big picture
The study highlights a growing trend in oncology toward precision communication tools that align patient care with individual goals, particularly as burnout and alert fatigue challenge clinicians. The findings suggest that small, targeted interventions can meaningfully improve care coordination and patient advocacy, especially for those with advanced cancer. The approach could influence broader healthcare practices aiming to enhance patient-provider communication through technology.
What we're watching
- Scalability
- Whether the nudge approach can be effectively scaled across diverse oncology practices without losing precision.
- Clinician Adoption
- The pace at which clinicians will integrate these targeted nudges into routine practice, given existing workloads.
- Patient Outcomes
- How sustained increases in serious illness conversations will impact long-term patient anxiety and quality of life.
Related topics